Eli Lilly and Company (BVMF:LILY34)

Eli Lilly and Company Revenue

Eli Lilly and Company had revenue of $17.60B USD in the quarter ending September 30, 2025, with 53.87% growth. This brings the company's revenue in the last twelve months to $59.42B, up 45.41% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.

• Revenue (ttm): $59.42B
• Revenue Growth: +45.41%
• P/S Ratio: 15.50
• Revenue / Employee: $1.26M
• Employees: 47,000
• Market Cap: 4.91T BRL

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	45.04B	10.92B	32.00%
Dec 31, 2023	34.12B	5.58B	19.56%
Dec 31, 2022	28.54B	223.00M	0.79%
Dec 31, 2021	28.32B	3.78B	15.40%
Dec 31, 2020	24.54B	2.22B	9.95%
Dec 31, 2019	22.32B	826.20M	3.84%
Dec 31, 2018	21.49B	1.52B	7.61%
Dec 31, 2017	19.97B	-1.25B	-5.88%
Dec 31, 2016	21.22B	1.26B	6.33%
Dec 31, 2015	19.96B	343.10M	1.75%
Dec 31, 2014	19.62B	-3.50B	-15.13%
Dec 31, 2013	23.11B	509.70M	2.25%
Dec 31, 2012	22.60B	-1.68B	-6.93%
Dec 31, 2011	24.29B	1.21B	5.25%
Dec 31, 2010	23.08B	1.24B	5.68%
Dec 31, 2009	21.84B	1.46B	7.19%
Dec 31, 2008	20.37B	1.74B	9.33%
Dec 31, 2007	18.63B	2.94B	18.75%
Dec 31, 2006	15.69B	1.05B	7.14%
Dec 31, 2005	14.65B	-	-